Cite
HARVARD Citation
Forst, T. et al. (n.d.). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes, obesity & metabolism. 16 (5), pp. 467-477. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Forst, T. et al. (n.d.). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes, obesity & metabolism. 16 (5), pp. 467-477. [Online].